BFRI - Biofrontera Inc.
0.83
0.006 0.723%
Share volume: 46,817
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.82
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-13-2024 | 03-20-2025 | 05-15-2025 | 11-12-2025 | |
| Total revenue | 7.912 M | 7.839 M | 9.012 M | 12.558 M | 8.588 M | 6.988 M | |
| Cost of revenue | 4.116 M | 4.342 M | 4.877 M | 5.272 M | 3.268 M | 2.045 M | |
| Gross profit | 3.796 M | 3.497 M | 4.135 M | 7.286 M | 5.320 M | 4.943 M | |
| -7.88% | 18.24% | 76.20% | -26.98% | -7.09% | |||
| Operating expenses | 9.263 M | 8.568 M | 9.095 M | 8.998 M | 9.860 M | 11.221 M | |
| Selling general and admin | 9.246 M | 7.947 M | 8.426 M | 8.216 M | 8.653 M | 10.367 M | |
| Research and development | 17.000 K | 621.000 K | 669.000 K | 782.000 K | 1.207 M | 854.000 K | |
| Total expenses | 9.263 M | 8.568 M | 9.095 M | 8.998 M | 9.860 M | 11.221 M | |
| -7.50% | 6.15% | -1.07% | 9.58% | 13.80% | |||
| Operating income | -5.467 M | -5.071 M | -4.960 M | -1.712 M | -4.547 M | -6.278 M | |
| Ebit | -8.716 M | 373.000 K | -5.672 M | -1.357 M | -4.098 M | -6.533 M | |
| Pretax income | -10.436 M | -237.000 K | -5.666 M | -1.398 M | -4.204 M | -6.643 M | |
| -97.73% | 2,290.72% | -75.33% | 200.72% | 58.02% | |||
| Income tax | 1.000 K | 20.000 K | 3.000 K | -2.000 K | -1.000 K | 6.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.437 M | -257.000 K | -5.669 M | -1.396 M | -4.203 M | -6.649 M | |
| 97.54% | -2,105.84% | 75.37% | -201.07% | -58.20% |